In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure (WB-Malaria)
Sponsor: Ministry of Health and Social Welfare, Tanzania
A PHASE4 clinical study on Malaria, this trial is completed. The trial is conducted by Ministry of Health and Social Welfare, Tanzania and has accumulated 7 data snapshots since 2014. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE4
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE4
-
Jan 2018 — Jun 2018 [monthly]
Completed PHASE4
Status: Unknown Status → Completed
▶ Show 2 earlier versions
-
Oct 2017 — Jan 2018 [monthly]
Unknown Status PHASE4
Status: Active Not Recruiting → Unknown Status
-
Jan 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE4
First recorded
May 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ministry of Health and Social Welfare, Tanzania
- National Institute for Medical Research, Tanzania
- World Health Organization
For direct contact, visit the study record on ClinicalTrials.gov .